ABACAVIR SULFATE and RASH

Overview

RASH is the #4 most commonly reported adverse reaction for ABACAVIR SULFATE, manufactured by ViiV Healthcare Company. There are 576 FDA adverse event reports linking ABACAVIR SULFATE to RASH. This represents approximately 1.9% of all 29,564 adverse event reports for this drug.

Patients taking ABACAVIR SULFATE who experience rash should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

RASH is a less commonly reported adverse event for ABACAVIR SULFATE, but still significant enough to appear in the safety profile.

Other Side Effects of ABACAVIR SULFATE

In addition to rash, the following adverse reactions have been reported for ABACAVIR SULFATE:

• PAIN — 846 reports
• PYREXIA — 829 reports
• NAUSEA — 615 reports
• VOMITING — 549 reports
• FATIGUE — 534 reports
• EXPOSURE DURING PREGNANCY — 527 reports
• OFF LABEL USE — 527 reports
• HEPATIC ENZYME INCREASED — 515 reports
• HYPERTENSION — 511 reports
• HEADACHE — 507 reports

Other Drugs Associated with RASH

The following drugs have also been linked to rash in FDA adverse event reports:

Does ABACAVIR SULFATE cause RASH?

RASH has been reported as an adverse event in 576 FDA reports for ABACAVIR SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is RASH with ABACAVIR SULFATE?

RASH accounts for approximately 1.9% of all adverse event reports for ABACAVIR SULFATE, making it a notable side effect.

What should I do if I experience RASH while taking ABACAVIR SULFATE?

If you experience rash while taking ABACAVIR SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages